Testicular cancer is the most commonly occurring cancer among young men (ages 15–40 years) in many countries, including the United States. The great majority of testicular cancers are testicular germ cell tumors (TGCTs), which can be further subdivided into seminomas, nonseminomas and spermatocytic tumors. Seminomas and nonseminomas are associated with other male reproductive disorders and are thought to be initiated in utero. MEB investigators conduct research on a variety of factors in relationship to testicular cancer including:
- Hormonal hypotheses
- Endocrine disrupting chemicals
- Racial/ethnic disparity in risk
- Genetic susceptibility
Resources focused specifically on testicular cancer include:
Testicular Cancer Among Military Servicemen: The STEED Study
A case-control study of testicular cancer among military servicemen
Testicular Cancer Consortium (TECAC)
A consortium of international studies to examine genetic susceptibility to testicular cancer
For more information, contact Katherine McGlynn.